Vera Therapeutics Investors

38 investors on Angel Roster list Vera Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and China.

Investors are matched on the company name in their portfolio, so companies that share the name Vera Therapeutics can appear together.

Investors listed
38
With verified email
55%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 38 Vera Therapeutics investors

The most complete profiles first. Showing 38 of 38.

  • Amar PatelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Beth SeidenbergVerified

    Venture Capital, Incubator, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Atara Biotherapeutics, ACELYRIN, iPierian, Mango Health and 16 more

    Verified email available

  • Brian LiuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Karthik BolisettyVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Krishna YeshwantVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    Series BHealth CareTelecommunicationsHospitalsE-commerce

    Portfolio: Pixie, Dialpad, Science 37, Synack and 90 more

    Verified email available

  • Michael WertVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Sonia ParekhVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Garrett HowardVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • John DoerrVerified

    Venture Capital · United States

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Verified email available

  • Josh CoyneVerified

    Venture Capital · United States

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Verified email available

  • Josh RichardsonVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Karim FarisVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareTelecommunicationsE-commerceConsumer Goods

    Portfolio: Pixie, Dialpad, Science 37, Synack and 87 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Annie Case

    Venture Capital, Investor · United States

    Series BWearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 85 more

    Contact details available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Maxwell Bikoff

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Carolyn Helms

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Marc

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Nikki Zhang

    Venture Capital · China

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Susan Biglieri

    Venture Capital · United States

    WearablesConsumer ResearchPaymentsMessaging

    Portfolio: Teleport, Nurx, Hallo, Incorta and 84 more

    Contact details available

  • Zander Liem

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Vera Therapeutics investors are on Angel Roster?

Angel Roster lists 38 Vera Therapeutics investors. 21 of them (55%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (38), Private Equity Firms (9) and Corporate Venture Capital Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Vera Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (10) and Series B (10).

Where are Vera Therapeutics investors based?

Most are based in the United States (31), the United Kingdom (5) and China (1).

Which companies have Vera Therapeutics investors backed?

The most-backed portfolio companies among them are Vaxcyte (21), Checkmate Pharmaceuticals (20), Neurana Pharmaceuticals (20), Inozyme (20) and Civitas Therapeutics (20).

How do I contact Vera Therapeutics investors?

Create a free Angel Roster account to search and filter all 38, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.